Literature DB >> 10483871

Serum haptoglobin, CA 125 and interleukin 6 levels in malignant and non-malignant tumors of the ovary.

W Dobryszycka1, I Katnik-Prastowska, J Gerber, K Lemańska, K Utko, K Rozdolski.   

Abstract

In sera of women with malignant and non-malignant ovarian tumors, concentrations of the following proteins were determined: haptoglobin, measured by the reactions either with hemoglobin (Hp-Hb) or with concanavalin A (Hp-Con A), CA 125 antigen and interleukin 6 (IL-6). Besides preoperative data, obtained from all the patients and the group of healthy women, in the patients with ovarian cancer (III/IV FIGO stages) effects of administration of cytostatics were measured by monitoring changes in the levels of the examined parameters through the course of the therapy. All the results were submitted to statistical evaluation which showed differences and correlations among definite groups (normal/non-malignant, normal/cancers, non-malignant/cancers). Similar results were obtained for Hp-Hb and CA 125 determination. Moreover, a correlation between haptoglobin level and age was found. Patterns of monitoring revealed a surprising absence of Hp-Con A interaction in some cases.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10483871

Source DB:  PubMed          Journal:  Arch Immunol Ther Exp (Warsz)        ISSN: 0004-069X            Impact factor:   4.291


  3 in total

1.  Circulating haptoglobin is an independent prognostic factor in the sera of patients with epithelial ovarian cancer.

Authors:  Changqing Zhao; Loganath Annamalai; Changfa Guo; Narasimhan Kothandaraman; Stephen Chee Liang Koh; Huoming Zhang; Arijit Biswas; Mahesh Choolani
Journal:  Neoplasia       Date:  2007-01       Impact factor: 5.715

2.  Proteomic-based identification of haptoglobin-1 precursor as a novel circulating biomarker of ovarian cancer.

Authors:  N Ahmed; G Barker; K T Oliva; P Hoffmann; C Riley; S Reeve; A I Smith; B E Kemp; M A Quinn; G E Rice
Journal:  Br J Cancer       Date:  2004-07-05       Impact factor: 7.640

3.  Elevated Interleukin-6 Levels in the Circulation and Peritoneal Fluid of Patients with Ovarian Cancer as a Potential Diagnostic Biomarker: A Systematic Review and Meta-Analysis.

Authors:  Hina Amer; Apriliana E R Kartikasari; Magdalena Plebanski
Journal:  J Pers Med       Date:  2021-12-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.